Nostrum Biodiscovery
PrivateLast Round
Grant
Jul 1, 2022
Total Funding Raised
$2.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nostrum Biodiscovery operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in July 2022.
Nostrum Biodiscovery is a biotechnology company that provides AI-powered molecular modeling and drug discovery services for the pharmaceutical and chemical industries.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nostrum Biodiscovery Comparables
Compare Nostrum Biodiscovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmacelera | 88% | |
| QSimulate | 78% | |
| Aganitha AI | 77% |
For institutional investors. Book with your work email.
Nostrum Biodiscovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2022 | ||||
| Grant | Dec 31, 2019 | ||||
| Seed | Jul 12, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nostrum Biodiscovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Center for Technological Development and Innovation | Grant |
| Fundación Botín | Seed |
| Spanish Government (Ministry of Science) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 135% MoM, reaching 2.6K.
- Apr 17, 2026
Monthly visitors increased 113% MoM.
For institutional investors. Book with your work email.
Nostrum Biodiscovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nostrum Biodiscovery's valuation, stock price, and market status.
Is Nostrum Biodiscovery a public or private company?
Nostrum Biodiscovery is a private company.
What is the current stock price of Nostrum Biodiscovery?
Nostrum Biodiscovery is a private company, so its shares have no public market price. Caplight tracks Nostrum Biodiscovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nostrum Biodiscovery worth (valuation)?
Valuation information for Nostrum Biodiscovery is not publicly available.
Can I buy Nostrum Biodiscovery stock?
Nostrum Biodiscovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nostrum Biodiscovery's last funding round?
Nostrum Biodiscovery's most recent funding round was Grant on July 1, 2022.
Who are the main investors in Nostrum Biodiscovery?
Key investors in Nostrum Biodiscovery include Center for Technological Development and Innovation, Fundación Botín, Spanish Government (Ministry of Science).
Will Nostrum Biodiscovery IPO soon?
No public IPO plans have been announced for Nostrum Biodiscovery.
How can I track Nostrum Biodiscovery secondary market activity?
Caplight tracks bids, offers, and trades in Nostrum Biodiscovery's shares on secondary markets.